Science Explorer Interactive view Map
Company · Heidelberg · Germany

Apogenix (Germany)

apogenix.com/enROR OpenAlex
Research works
60
▲ 166% vs 2013–17
Citations
1.2k
19.4 per fractional work
Top-10% rate
10.8%
record average 16.5%
Open access
31%
world 28%

Not ranked overall: Apogenix (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.66× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 12.76× its world share, 1 worksImmunology and Micro…Computer Science: 1.16× its world share, 0 worksComputer ScienceEngineering: 0.67× its world share, 0 worksEngineeringEnvironmental Science: 1.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.41× its world share, 0 worksMaterials ScienceMedicine: 1.68× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 11.81× its world share, 1 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.8×. Every wedge is a field page.

Which keywords describe research at Apogenix (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Innate Immunity, Dendritic Cells, Antigen Presentation, Tumor Antigen, Immunotherapy and Glycosylation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy10▲ 115×3 topics
  2. Immunity9▲ 43×4 topics
  3. Innate Immunity8▲ 40×5 topics
  4. Dendritic Cells7▲ 101×2 topics
  5. Antigen Presentation7▲ 116×1 topic
  6. Tumor Antigen7▲ 142×1 topic
  7. Immunotherapy6▲ 16×7 topics
  8. Glycosylation6▲ 43×3 topics
  9. Monoclonal Antibodies5▲ 63×2 topics
  10. Fc Receptors5▲ 83×1 topic
  11. Therapeutic Antibodies5▲ 64×1 topic
  12. Tumor Microenvironment5▲ 23×4 topics
  13. Immune Checkpoint Blockade4▲ 125×1 topic
  14. PD-1 and PD-L14▲ 125×1 topic
  15. Inflammation4▲ 2.5×11 topics
  16. Cancer3▲ 4.1×9 topics
  17. NK Cell Recognition3▲ 54×1 topic
  18. Natural Killer Cells3▲ 54×1 topic
  19. Tumor Regression3▲ 62×2 topics
  20. Lymphoma2▲ 29×2 topics
  21. Cancer Therapy2▲ 6.4×6 topics
  22. Quality of Life2▲ 2.9×2 topics
  23. Cost-effectiveness Analysis2▲ 50×1 topic
  24. Health Utility Measures2▲ 50×1 topic
  25. Targeted Therapy2▲ 17×3 topics
  26. CAR T Cells2▲ 82×1 topic
  27. Chimeric Antigen Receptor2▲ 82×1 topic
  28. Radiotherapy2▲ 9.2×2 topics
  29. Reactive Oxygen Species2▲ 6.9×2 topics
  30. Glioblastoma2▲ 54×1 topic
  31. Temozolomide2▲ 54×1 topic
  32. Tumor Targeting2▲ 24×3 topics
  33. Clinical Trials2▲ 4.9×4 topics
  34. Pharmaceutical Industry2▲ 69×2 topics
  35. Activation2▲ 77×1 topic
  36. Apoptosis2▲ 6.8×3 topics
  37. Gene Therapy2▲ 9.9×3 topics
  38. Macrophage2▲ 48×1 topic
  39. Drug Development Costs2▲ 99×1 topic
  40. Generic Drugs2▲ 99×1 topic

Which research topics does Apogenix (Germany) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Coastal and Marine Management and Opportunistic and Delay-Tolerant Networks.

Health Systems, Economic Evaluations, Quality of Life: 0 fractional worksPharmaceutical Economics and Policy: 0 fractional worksCoastal and Marine Manag…0Coastal and Marine Management: 0 fractional worksOpportunistic and Delay-…0Opportunistic and Delay-Tolerant Networks: 0 fractional worksBiomedical Ethics and Regulation: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional worksEconomic and Financial I…0Economic and Financial Impacts of Cancer: 0 fractional worksMacrophage Migration Inh…0Macrophage Migration Inhibitory Factor: 0 fractional worksImmune cells in cancer0Immune cells in cancer: 0 fractional worksSystems Engineering Meth…0Systems Engineering Methodologies and Applications: 0 fractional works
Economics and EconometricsManagement, Monitoring, Policy and LawComputer Networks and CommunicationsPhysiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  2. 2 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  3. 3 Coastal and Marine Management Management, Monitoring, Policy and Law 0 works
  4. 4 Opportunistic and Delay-Tolerant Networks Computer Networks and Communications 0 works
  5. 5 Biomedical Ethics and Regulation Physiology 0 works
  6. 6 Glioma Diagnosis and Treatment Genetics 0 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  8. 8 Macrophage Migration Inhibitory Factor Immunology 0 works
  9. 9 Immune cells in cancer Immunology 0 works
  10. 10 Systems Engineering Methodologies and Applications Control and Systems Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.9%not open69.1%

World: 28% of research is openly available.

with international co-authors14.8%domestic only85.2%

World: 19% is written across borders.

How has Apogenix (Germany)'s research output changed?

Output in 2018–2022 was 166% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Heidelberg

All research institutions in Heidelberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.